| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2022 - PRIN bando 2022 |
PAtient Lipidome As biomarker of Cancer immunothErapy (PALACE study)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
SLC15A4 (Solute Carrier 15 member A4): integrated in vitro-in vivo analysis and functional characterization
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Organic cation transporters relevant to drug discovery: multifaceted approaches to unravel their structure/function relationships with the aim of identifying novel substrates and inhibitors enabling their application in therapy
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
The cellular function of SERINC proteins and their role in retroviral infection.
|
|
Ongoing | 2023 |
| PRIN2020 - PRIN bando 2020 |
RE-Plast: targeting functional and structural plasticity in Alzheimer disease. From diagnosis to treatment
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
New interventional approaches on multiple inflammatory pathways involved in regeneration after trauma and aging- associated diseases
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Role of TDP-43 self-assembly in health and disEase: molecular characteristics, cellular Aspects and animal Models
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Escaping the ESKAPEs: integrated pipelines for new antibacterial drugs
|
|
Ongoing | 2022 |
| PRIN2017 - PRIN bando 2017 |
Molecular pathways in Schwannomatosis: exploiting in vitro models for the identification of new therapeutic targets
|
|
Closed | 2019 |
| PRIN2017 - PRIN bando 2017 |
Integrating metabolism and immunity: cellular and molecular pathways leading to metabolic dysregulation and autoimmunity
|
|
Closed | 2019 |
